Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors

Haemophilia. 2018 Nov;24(6):e417-e420. doi: 10.1111/hae.13603. Epub 2018 Aug 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Animals
  • Antibodies, Neutralizing / blood
  • Autoantibodies / blood
  • Biomarkers, Pharmacological / metabolism
  • Blood Coagulation
  • Factor XIII / immunology
  • Factor XIII / metabolism*
  • Factor XIII Deficiency / diagnosis*
  • Factor XIII Deficiency / therapy
  • Hemorrhage / diagnosis*
  • Hemorrhage / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Mycophenolic Acid / therapeutic use*
  • Prognosis
  • Risk

Substances

  • Antibodies, Neutralizing
  • Autoantibodies
  • Biomarkers, Pharmacological
  • Immunosuppressive Agents
  • Factor XIII
  • Mycophenolic Acid